Prashant Shringi
Senior resident Neurology
Govt. Medical College Kota
 Generalized term including disorders of any
cause affecting PNS
 May involve sensory nerves, motor nerves, or
both or autonomic nerves
 May affect one nerve (mononeuropathy),
several nerves together (polyneuropathy) or
several nerves not contiguous
(Mononeuropathy multiplex)
 Mononeuritis multiplex is a painful,
asymmetrical, asynchronous sensory and
motor peripheral neuropathy involving
simultaneous or sequential damage to two or
more noncontiguous peripheral nerves .
 : Bradely’s neurology in clinical practice 7th edition
 As the condition worsens, it becomes less
multifocal and more symmetrical.
 Mononeuropathy multiplex syndromes can be
distributed bilaterally, distally, and proximally
throughout the body.
 Mononeuritis multiplex actually is a group of
disorders, not a true, distinct disease entity.
Typically, the condition is associated with
(but not limited to) systemic disorders such
as the following
 Leprosy
 Diabetes mellitus
 Vasculitis
 The damage to the nerves involves
destruction of the axon and therefore
interferes with nerve conduction.
 Common causes of damage include a lack of
oxygen from decreased blood flow or
inflammation of blood vessels causing
destruction of the vessel wall and occlusion
of the vessel lumen of small epineurial
arteries.
 Mononeuritis multiplex can be associated
with many different conditions.
 Infections
 Rheumatological disorders
 Chronic conditions
 Malingnancy
 Hematological conditions
 Mononeuritis multiplex can be associated
with the following infections:
 Lyme disease
 Leprosy
 Acute viral hepatitis A
 Hepatitis B
 Hepatitis C
 Acute parvovirus B-19 infection
Herpes simplex virus infection
 AIDS and HIV infection
 Mononeuritis multiplex can be associated
with the following rheumatological disorders:
 Wegener granulomatosis
 Henoch-Schönlein syndrome
 Sjögren syndrome
 Behçet’s disease
 Temporal (giant cell) arteritis
 Systemic lupus erythematosus
 Rheumatoid arthritis
 Polyarteritis nodosa
 Scleroderma
 Mononeuritis multiplex can be associated
with the following chronic conditions:
 Diabetes mellitus
 Amyloidosis
 Neurosarcoidosis
 Celiac disease
 Mononeuritis multiplex can be associated
with the following cancer-related conditions:
 Chronic graft versus host disease (GVHD)
 Direct tumor invasion with intraneural spread
– Lymphoma, B-cell leukemia, carcinoid
tumor
 Paraneoplastic – Small cell lung cancer
 Mononeuritis multiplex can be associated
with the following hematologic conditions:
 Churg-Strauss syndrome
 Hypereosinophilia
 Cryoglobulinemia
 Hypereosinophilia
 Atopy-related peripheral neuritis
 Idiopathic thrombocytopenic purpura
 Mononeuritis multiplex can be associated
with the following miscellaneous conditions:
 Amphetamine angiitis
 Gasoline sniffing
 In addition, mononeuritis multiplex can be
associated with the genetic disorder Tangier
disease and with multiple compression
neuropathies.
 Persons with one occurrence of mononeuritis
multiplex are more prone to a recurrence.
Mononeuritis multiplex can become
progressively worse over time. Approximately
33% of cases originate from unidentifiable
causes.
 The actual incidence of mononeuritis
multiplex is not known due to the widely
varied etiologies that may lead to this
disorder.
 The primary disease process often is so
dominant that the symptoms of mononeuritis
multiplex simply are attributed to the initial
disease and remain undiagnosed.
 The age of onset for mononeuritis multiplex
depends on the patient's age at occurrence of
the associated disease process.
 For unknown reasons, however, this condition
does tend to occur in older patients with
relatively mild or unrecognized diabetes.
 If the cause of mononeuritis multiplex is
identified early and is successfully treated,
full recovery is possible, although it may take
months to years. The same syndrome has a
tendency to recur after an interval of months
or years.
 The extent of disability varies, ranging from
no disability to partial or complete loss of
function and movement.
 Complications in mononeuritis multiplex include
the following:
 Recurrent or unnoticed injury to any part of the
body
 Deformity
 Atrophy
 Disturbances of organ functions that are
autonomically controlled (eg, cardiac, gastric,
bladder)
 Decreased self-esteem and decreased social
interaction due to an inability to participate in
activities because of pain or incoordination
 Relationship problems associated with impotence
 The suspected cause of mononeuritis
multiplex, as suggested by the patient’s
history, symptoms, and pattern of symptom
development, helps to determine which tests
to perform.
 A detailed and complete medical history is
vitally important in determining the possible
underlying cause of mononeuritis multiplex.
 The pain usually is characterized as deep and
aching, with superimposed lancinating jabs
that are most severe at night.
 All patients should be questioned regarding -
• HIV risk factors
• possibility of a tick bite (Lyme disease)
• Constitutional symptoms (malignancy) like
weight loss, malaise, anorexia.
 Individuals with Diabetes typically present
with acute onset of severe, unilateral thigh
pain that is followed rapidly by weakness and
atrophy of the anterior thigh muscles and
loss of the ankle reflex.
Other possible symptoms that may be reported
by the patient include the following:
 Numbness
 Tingling
 Abnormal sensation
 Burning pain - Dysesthesia
 Difficulty moving a body part - Paralysis
 Lack of controlled movement of a body part
 Loss of sensation and movement may be
associated with dysfunction of specific
nerves.
 Examination reveals preservation of reflexes
and good strength except in regions that
have been more profoundly affected.
 Some common findings of mononeuritis
multiplex are as follows
 Sciatic nerve dysfunction
 Femoral nerve dysfunction
 Common peroneal nerve dysfunction
 Axillary nerve dysfunction
 Radial nerve dysfunction
 Median nerve dysfunction
 Ulnar nerve dysfunction
 Peroneal nerve palsy
 Autonomic dysfunction - Dysfunction in the
part of the nervous system that controls
involuntary bodily functions, such as the
glands, blood vessels, and heart.
 Laboratory tests include the following:
 Complete blood count (CBC) with a
differential
 Fasting blood glucose levels
 Borrelia burgdorferi antibody titer - If Lyme
disease is suspected
 Human immunodeficiency virus (HIV) blood
tests - If HIV infection is suspected
 Hepatitis screen - If hepatitis is suspected as
a causative agent
 Erythrocyte sedimentation rate (ESR) and C-
reactive protein level - If a systemic
inflammatory process is suspected.
 Herpes viridae serology
 Parvovirus B-19 antibodies
 Autoimmune profile
 Extensive vasculitic and rheumatological
workup include
 ANA, RF, Anti-dsDNA, Anti-Ro, Anti-La,
ANCA screen, cryoglobulins
 Serum protein electrophoresis
 In some cases, a nerve biopsy may be
appropriate to determine the underlying
cause of mononeuritis multiplex (usually a
combination of perivascular mononuclear
inflammatory cells and multifocal axonal loss
and axonal loss with multinucleated
inflammatory cells) .
 A pattern of necrotizing vasculitis of
epineural arteries may be observed in HIV-
related mononeuritis.
 Some studies have indicated that combining a
nerve biopsy with a muscle biopsy can help
clinicians to better diagnose peripheral nerve
vasculitis, because it appears that in many
cases, individuals with peripheral nerve
vasculitis also have vasculitis in striated
muscle.
 Electrodiagnostic studies are used only in
conjunction with an accurate and complete
history and physical examination.
 The lesion or lesions are distal to the motor
and sensory cell bodies and result in either
axonal disruption/degeneration or abnormal
axonal conduction.
 Sensory nerve conduction studies (NCSs)
show abnormalities of decreased amplitude in
the presence of axonal disruption.
 H-reflex latencies may be prolonged or
absent in mononeuritis multiplex. However,
the H-reflex is typically performed only in the
tibial nerves, limiting its usefulness in
investigating mononeuritis multiplex.
 Abnormalities are similar to those seen in
axonal polyneuropathies, with the exception
of the anatomic distribution. A reduction in
the motor action potential amplitudes and
minimal alterations in nerve conduction
velocity will be seen.
 Findings on the needle electrode examination
can vary, depending on the severity and time
course of the disorder..
 Findings are typically neuropathic and may
include abnormal spontaneous membrane
activity (positive sharp waves and fibrillation
potentials) and, during and after
reinnervation, increases in motor unit action
potential (MUAP) duration, amplitude, and
polyphasic potentials.
 Slow progression
-Treat causative factors if possible
 Symptom Management
 Tricyclic antidepressants
◦ Amitryptilin, nortryptilin
 Calcium channel alpha-2-delta ligands
◦ Gabapentin, pregabalin
 Calcium channel blocker
 Prialt (Ziconotide)
 SNRI’s
◦ Duloxetine, venlafaxine
 Topical Agents
◦ Lidocaine, Capsaicin
 Antiepileptic Drugs
◦ Carbamazepine, phenytoin, lacosamide
 SSRI’s
 Opioid analgesics
 Tramadol
 Miscellaneous
◦ Botulinum toxin
◦ Mexiletine
◦ Alpha lipoic acid
 NMDA receptors unsuccessful
◦ Namenda, Dextromethorphan
 First line drugs
 Lidoderm 5% patch
 Tricyclic antidepressants
 Gabapentin
 Pregabalin p.o.
 Duloxetine
 Second line
 Carbamazepine
 Phenytoin
 Venlafaxine
 Tramadol
 Physical Therapy
◦ Gait and balance training
 Assistive devices
 Safe environment
 Footwear at all times
 Foot hygiene
 If the causative factor for a patient's
mononeuritis multiplex is discovered,
education is directed toward avoidance of the
initiating cause or pathogen. Additionally,
recognition of early symptomology should be
encouraged so that early treatment can be
sought.

THANK YOU
 Bradely’s neurology in clinical practice 7th
edition
 An Approach to the Evaluation of Peripheral
Neuropathies;Mark B. Bromberg; SEMINARS IN
NEUROLOGY/VOLUME 30, NUMBER 4 2010
 Medscape.com

Mononeritis multiplex

  • 1.
    Prashant Shringi Senior residentNeurology Govt. Medical College Kota
  • 2.
     Generalized termincluding disorders of any cause affecting PNS  May involve sensory nerves, motor nerves, or both or autonomic nerves  May affect one nerve (mononeuropathy), several nerves together (polyneuropathy) or several nerves not contiguous (Mononeuropathy multiplex)
  • 3.
     Mononeuritis multiplexis a painful, asymmetrical, asynchronous sensory and motor peripheral neuropathy involving simultaneous or sequential damage to two or more noncontiguous peripheral nerves .  : Bradely’s neurology in clinical practice 7th edition
  • 4.
     As thecondition worsens, it becomes less multifocal and more symmetrical.  Mononeuropathy multiplex syndromes can be distributed bilaterally, distally, and proximally throughout the body.
  • 5.
     Mononeuritis multiplexactually is a group of disorders, not a true, distinct disease entity. Typically, the condition is associated with (but not limited to) systemic disorders such as the following  Leprosy  Diabetes mellitus  Vasculitis
  • 6.
     The damageto the nerves involves destruction of the axon and therefore interferes with nerve conduction.
  • 7.
     Common causesof damage include a lack of oxygen from decreased blood flow or inflammation of blood vessels causing destruction of the vessel wall and occlusion of the vessel lumen of small epineurial arteries.
  • 8.
     Mononeuritis multiplexcan be associated with many different conditions.  Infections  Rheumatological disorders  Chronic conditions  Malingnancy  Hematological conditions
  • 9.
     Mononeuritis multiplexcan be associated with the following infections:  Lyme disease  Leprosy  Acute viral hepatitis A  Hepatitis B  Hepatitis C  Acute parvovirus B-19 infection Herpes simplex virus infection  AIDS and HIV infection
  • 10.
     Mononeuritis multiplexcan be associated with the following rheumatological disorders:  Wegener granulomatosis  Henoch-Schönlein syndrome  Sjögren syndrome  Behçet’s disease  Temporal (giant cell) arteritis
  • 11.
     Systemic lupuserythematosus  Rheumatoid arthritis  Polyarteritis nodosa  Scleroderma
  • 12.
     Mononeuritis multiplexcan be associated with the following chronic conditions:  Diabetes mellitus  Amyloidosis  Neurosarcoidosis  Celiac disease
  • 13.
     Mononeuritis multiplexcan be associated with the following cancer-related conditions:  Chronic graft versus host disease (GVHD)  Direct tumor invasion with intraneural spread – Lymphoma, B-cell leukemia, carcinoid tumor  Paraneoplastic – Small cell lung cancer
  • 14.
     Mononeuritis multiplexcan be associated with the following hematologic conditions:  Churg-Strauss syndrome  Hypereosinophilia  Cryoglobulinemia  Hypereosinophilia  Atopy-related peripheral neuritis  Idiopathic thrombocytopenic purpura
  • 15.
     Mononeuritis multiplexcan be associated with the following miscellaneous conditions:  Amphetamine angiitis  Gasoline sniffing  In addition, mononeuritis multiplex can be associated with the genetic disorder Tangier disease and with multiple compression neuropathies.
  • 16.
     Persons withone occurrence of mononeuritis multiplex are more prone to a recurrence. Mononeuritis multiplex can become progressively worse over time. Approximately 33% of cases originate from unidentifiable causes.
  • 17.
     The actualincidence of mononeuritis multiplex is not known due to the widely varied etiologies that may lead to this disorder.  The primary disease process often is so dominant that the symptoms of mononeuritis multiplex simply are attributed to the initial disease and remain undiagnosed.
  • 18.
     The ageof onset for mononeuritis multiplex depends on the patient's age at occurrence of the associated disease process.  For unknown reasons, however, this condition does tend to occur in older patients with relatively mild or unrecognized diabetes.
  • 19.
     If thecause of mononeuritis multiplex is identified early and is successfully treated, full recovery is possible, although it may take months to years. The same syndrome has a tendency to recur after an interval of months or years.  The extent of disability varies, ranging from no disability to partial or complete loss of function and movement.
  • 20.
     Complications inmononeuritis multiplex include the following:  Recurrent or unnoticed injury to any part of the body  Deformity  Atrophy  Disturbances of organ functions that are autonomically controlled (eg, cardiac, gastric, bladder)  Decreased self-esteem and decreased social interaction due to an inability to participate in activities because of pain or incoordination  Relationship problems associated with impotence
  • 21.
     The suspectedcause of mononeuritis multiplex, as suggested by the patient’s history, symptoms, and pattern of symptom development, helps to determine which tests to perform.
  • 22.
     A detailedand complete medical history is vitally important in determining the possible underlying cause of mononeuritis multiplex.  The pain usually is characterized as deep and aching, with superimposed lancinating jabs that are most severe at night.
  • 23.
     All patientsshould be questioned regarding - • HIV risk factors • possibility of a tick bite (Lyme disease) • Constitutional symptoms (malignancy) like weight loss, malaise, anorexia.
  • 24.
     Individuals withDiabetes typically present with acute onset of severe, unilateral thigh pain that is followed rapidly by weakness and atrophy of the anterior thigh muscles and loss of the ankle reflex.
  • 25.
    Other possible symptomsthat may be reported by the patient include the following:  Numbness  Tingling  Abnormal sensation  Burning pain - Dysesthesia  Difficulty moving a body part - Paralysis  Lack of controlled movement of a body part
  • 26.
     Loss ofsensation and movement may be associated with dysfunction of specific nerves.  Examination reveals preservation of reflexes and good strength except in regions that have been more profoundly affected.
  • 27.
     Some commonfindings of mononeuritis multiplex are as follows  Sciatic nerve dysfunction  Femoral nerve dysfunction  Common peroneal nerve dysfunction  Axillary nerve dysfunction  Radial nerve dysfunction
  • 28.
     Median nervedysfunction  Ulnar nerve dysfunction  Peroneal nerve palsy  Autonomic dysfunction - Dysfunction in the part of the nervous system that controls involuntary bodily functions, such as the glands, blood vessels, and heart.
  • 29.
     Laboratory testsinclude the following:  Complete blood count (CBC) with a differential  Fasting blood glucose levels  Borrelia burgdorferi antibody titer - If Lyme disease is suspected  Human immunodeficiency virus (HIV) blood tests - If HIV infection is suspected
  • 30.
     Hepatitis screen- If hepatitis is suspected as a causative agent  Erythrocyte sedimentation rate (ESR) and C- reactive protein level - If a systemic inflammatory process is suspected.  Herpes viridae serology  Parvovirus B-19 antibodies
  • 31.
     Autoimmune profile Extensive vasculitic and rheumatological workup include  ANA, RF, Anti-dsDNA, Anti-Ro, Anti-La, ANCA screen, cryoglobulins  Serum protein electrophoresis
  • 32.
     In somecases, a nerve biopsy may be appropriate to determine the underlying cause of mononeuritis multiplex (usually a combination of perivascular mononuclear inflammatory cells and multifocal axonal loss and axonal loss with multinucleated inflammatory cells) .
  • 33.
     A patternof necrotizing vasculitis of epineural arteries may be observed in HIV- related mononeuritis.
  • 36.
     Some studieshave indicated that combining a nerve biopsy with a muscle biopsy can help clinicians to better diagnose peripheral nerve vasculitis, because it appears that in many cases, individuals with peripheral nerve vasculitis also have vasculitis in striated muscle.
  • 37.
     Electrodiagnostic studiesare used only in conjunction with an accurate and complete history and physical examination.  The lesion or lesions are distal to the motor and sensory cell bodies and result in either axonal disruption/degeneration or abnormal axonal conduction.
  • 38.
     Sensory nerveconduction studies (NCSs) show abnormalities of decreased amplitude in the presence of axonal disruption.  H-reflex latencies may be prolonged or absent in mononeuritis multiplex. However, the H-reflex is typically performed only in the tibial nerves, limiting its usefulness in investigating mononeuritis multiplex.
  • 39.
     Abnormalities aresimilar to those seen in axonal polyneuropathies, with the exception of the anatomic distribution. A reduction in the motor action potential amplitudes and minimal alterations in nerve conduction velocity will be seen.
  • 40.
     Findings onthe needle electrode examination can vary, depending on the severity and time course of the disorder..
  • 41.
     Findings aretypically neuropathic and may include abnormal spontaneous membrane activity (positive sharp waves and fibrillation potentials) and, during and after reinnervation, increases in motor unit action potential (MUAP) duration, amplitude, and polyphasic potentials.
  • 42.
     Slow progression -Treatcausative factors if possible  Symptom Management
  • 43.
     Tricyclic antidepressants ◦Amitryptilin, nortryptilin  Calcium channel alpha-2-delta ligands ◦ Gabapentin, pregabalin  Calcium channel blocker  Prialt (Ziconotide)  SNRI’s ◦ Duloxetine, venlafaxine  Topical Agents ◦ Lidocaine, Capsaicin
  • 44.
     Antiepileptic Drugs ◦Carbamazepine, phenytoin, lacosamide  SSRI’s  Opioid analgesics  Tramadol  Miscellaneous ◦ Botulinum toxin ◦ Mexiletine ◦ Alpha lipoic acid  NMDA receptors unsuccessful ◦ Namenda, Dextromethorphan
  • 45.
     First linedrugs  Lidoderm 5% patch  Tricyclic antidepressants  Gabapentin  Pregabalin p.o.  Duloxetine  Second line  Carbamazepine  Phenytoin  Venlafaxine  Tramadol
  • 46.
     Physical Therapy ◦Gait and balance training  Assistive devices  Safe environment  Footwear at all times  Foot hygiene
  • 47.
     If thecausative factor for a patient's mononeuritis multiplex is discovered, education is directed toward avoidance of the initiating cause or pathogen. Additionally, recognition of early symptomology should be encouraged so that early treatment can be sought.
  • 48.
  • 49.
     Bradely’s neurologyin clinical practice 7th edition  An Approach to the Evaluation of Peripheral Neuropathies;Mark B. Bromberg; SEMINARS IN NEUROLOGY/VOLUME 30, NUMBER 4 2010  Medscape.com